Skip to main content

Tag: CHIL

The Parable of the Two Molecules

On a quiet morning in a town that could be anywhere—though, in truth, it sits under a
blazing Texan sun—two figures stand at a crossroads. One is an old farmer, face lined
with decades of toiling in the fields, familiar with the gentle hum of wind through
cannabis leaves. He smiles easily, remembering a time when all he had was the plant,
its naturally occurring Delta-9 THC dancing beneath the sun, a secret he could trust.
The other figure, a young chemist in a crisp white lab coat, fresh from a makeshift
laboratory hidden behind a steel door, cradles a vial of something new, something
strange: a synthesized cannabinoid conjured not by nature, but by human ingenuity.

They meet by a rickety wooden sign that reads: “HEMP—0.3% THC LIMIT.” It’s a relic
from a not-so-distant past, a guideline that changed the course of everything. On one
side of the sign, fields of hemp sway under legally sanctioned skies, their Delta-9 THC
content tightly bound by regulation. On the other side, a world of possibility and
confusion blooms—hemp-derived molecules twisted, converted, and reshaped into
something both eerily familiar and unstintingly new: Delta-8, THCP, HHC, and more.

The farmer remembers a hypothetical: If you could hop into a time machine—say, back
to 2018—and whisper in the ear of a president, “Legalize cannabis outright,” would all of
this tinkering have been necessary? Would there be a room full of chemists bending
molecules to comply with laws rather than to discover truth? One timeline might have
yielded an abundance of natural Delta-9 THC, openly grown, studied, and enjoyed
without the shadowy dance around percentages. But in the timeline we have, clever
minds spotted a legal loophole and seized it. Thus, a new era was born.

The chemist, for their part, isn’t some cartoon villain. They are a seeker of knowledge.
They might say, “Nature is wondrous, but so is the human mind. If we can create a
molecule that offers therapeutic benefits that Delta-9 can’t, why not do it?” Yet the
farmer counters, “If we’d just started by legalizing the original plant, would we have even
bothered? Isn’t Mother Nature’s original blueprint enough?”

People come from all corners to argue. Some say these synthetic cannabinoids have
opened doors: they’ve allowed consumers in places like Texas to experience something
close to the Delta-9 high without openly defying the law. They’ve ushered in a future
where new pharmaceuticals and nutraceuticals might arise—substances that could help
ailments where old solutions fell short. Others warn of unknown dangers. Unregulated
synthetics have sent people reeling into hospital beds, their minds spinning into worlds
they never wanted to see. Safety data is thin, and no one’s quite sure what happens
when these new molecules dance in human biology over the long term.
In the distance, smoke rises from another battlefield. Texas lawmakers threaten to end
all THC sales—Delta-9, Delta-8, and everything in between—citing confusion, public

safety, and unforeseen consequences of the hemp loophole. Thousands of shop
owners face ruin. Consumers who rely on these cannabinoids for relief may lose their
access entirely. This ban wouldn’t just target the chemists and the labs; it would also
strike at the humble farmers and their fields of green. One might ask: Whose fault is this
tightening noose? The natural Delta-9 that sparked fear long ago, or the synthetic
creations that emerged only because Delta-9 was kept at arm’s length?
And what of medicine? The Texas Compassionate Use Program (TCUP) only permits
naturally occurring cannabinoids. There’s a sanctity, it seems, in what the plant chooses
to provide. Yet, shouldn’t we at least ask if the new synthetics deserve study and
scrutiny in clinical environments? Could they be tamed, understood, and perhaps one
day trusted? Or should they remain at the edges, a wild frontier too dangerous to bring
into the doctor’s office?

These questions swirl like smoke in the twilight air. The farmer and the chemist watch
the horizon. They know lawmakers, lobbyists, patients, and business owners are all
involved—everyone is shouting, everyone is pushing, everyone is pulling. It’s a war of
definitions: What is natural? What is safe? What should be allowed? And beneath these
questions lies an even deeper one: Who are we to decide what belongs in our bodies,
and at what cost?

By now, we are all standing at that crossroads, squinting into a future fogged by
uncertainty. Does the “natural” inherently mean safer, better, more ethical? Or does
human innovation hold a torch that illuminates pathways nature never considered? If
time were reversed, would we just legalize Delta-9 THC and spare ourselves this maze
of molecular modifications? Or would we still crave something new, different, and
perhaps better?

scientist experimenting with cannabis in the lab made with AI

In the end, the figures fade, and we are left with the riddle itself. Just as Hamlet once
pondered “To be or not to be,” we are left wondering: to inhale the old ways or embrace
the new; to trust nature’s leaf or trust the alchemy of the lab; to ban them all or find a
delicate balance.

We stand, each of us, at that same dusty crossroads, knowing there is no easy answer.
In our hesitation, we discover that we are not truly debating chemistry or law. We are
asking who we are as a society—our values, our hopes, our fears. And perhaps, in that
silent pause, we will learn something about existence itself.

Anthocyanins: Nature’s Antioxidant is Also Found in Hemp

Texas A&M Student MJ Clay Takes a Closer Look at This Pigment-Producing Compound

 

By Rachel Nelson

 

College is a place where students prepare for future careers while transitioning into full-blown adulthood. For MJ Clay, it’s a time to conduct groundbreaking hemp research and help pioneer one of the first-of-its-kind university cannabis clubs — the Cannabis Hemp Innovation League (CHIL).

 

Clay is a horticulture science and plant environmental science major at Texas A&M University, While she has completed a variety of work at the school’s Industrial Hemp Breeding Program, Clay said she has taken a special liking to trichomes — the part of the plant responsible for producing cannabinoids and terpenes.

 

According to Clay, trichomes can also contain anthocyanins, or naturally occurring pigments that create red and purple hues. Anthocyanins give foods like blueberries and raspberries their color, she said.

 

“When we’re learning about his plant, it’s as useful as the vegetables and fruits that we eat in our daily meals. I love how interconnected nature is. It’s quite beautiful, really. But [anthocyanins also have] incredible health benefits for humans,” Clay said, citing their antioxidant and antiviral properties.

 

“There’s actually some arguments about whether or not higher anthocyanins could take away from either terpenes, which are the smells, or cannabinoids like CBD or THC,” Clay said. “So we just need more research, but that’s why the Industrial Hemp Breeding Program is here.”

Currently, Clay is working with private companies on an inbreeding project focused on creating uniform cannabis similar to how rows of corn grow.

“So then we could do field seeding, and your crops would all look the same,” she said. “We’re also trying to select for the plants that have higher anthocyanins, not only because it has a great benefit to the users but it also gives the plants some tolerance to heat and drought.”

 

Clay said that although she works in controlled environments, part of her research includes stressing plants out by heating the room to 99 degrees at times.

 

“The plant really shows you a lot of different genetic traits that we didn’t know were possible,” Clay said. “If a plant is able to bounce back more readily than another, we know that plant is going to do better in field conditions in Texas, so whenever we find a plant that’s just resilient, we want to continue those genetics.”

 

Clay presented some of her research at the second annual Texas Hemp Summit at Texas A&M University in December. The summit is organized by the Texas Hemp Coalition, an advocacy and educational nonprofit. Clay and her counterparts from CHIL were also part of the inaugural Texas Hemp Summit in 2022.

 

“it was really rewarding because we were just kind of introducing the club,” she said. “Coming back the second time around at the summit and seeing so many familiar faces and so many people just supporting the work we’re doing at A&M — It’s really rewarding. Having one of the first cannabis clubs at a university has been quite a feat for us. We’re very proud of what we do, and we’re just hoping to continue growing our organization.”